Natural killer cells in clinical development as non-engineered, engineered, and combination therapies

Overview of attention for article published in Journal of Hematology & Oncology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 97 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 8,007 followers.

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies | Journal of Hematology & Oncology | Full Text https://t.co/wq1q0dc9QA

15 Nov 2022

Reply Repost Favourite

RT @NKcellBiology: Natural killer cells in clinical development as non-engineered, engineered, and combination therapies https://t.co/EVJ4M…

10 Nov 2022

Reply Repost Favourite

RT @NKcellBiology: Natural killer cells in clinical development as non-engineered, engineered, and combination therapies https://t.co/EVJ4M…

10 Nov 2022

Reply Repost Favourite

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies https://t.co/EVJ4MS1GVr

10 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.